KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach

Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification

(2015) Stacy Loeb et al.   EUROPEAN UROLOGY

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

(2014) Eric A. Klein et al.   EUROPEAN UROLOGY

DACH1: Its Role as a Classifier of Long Term Good Prognosis in Luminal Breast Cancer

(2014) Desmond G. Powe et al.   PLoS One

Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer

(2013) Siao-Yi Wang et al.   BJU INTERNATIONAL

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

(2013) Dejan Knezevic et al.   BMC GENOMICS

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

(2013) G Fisher et al.   BRITISH JOURNAL OF CANCER

Ki-67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08

(2013) Bret Verhoven et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma

(2013) Peng Tang   WORLD JOURNAL OF GASTROENTEROLOGY

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

(2013) Srikanth Nagalla et al.   GENOME BIOLOGY

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

(2012) J Cuzick et al.   BRITISH JOURNAL OF CANCER

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy

(2012) Emmanuel S. Antonarakis et al.   CANCER

ERK5 signalling in prostate cancer promotes an invasive phenotype

(2011) A K Ramsay et al.   BRITISH JOURNAL OF CANCER

Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis

(2011) Mahmut Yilmaz et al.   EMBO JOURNAL

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

(2011) Jack Cuzick et al.   LANCET ONCOLOGY

Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis

(2011) Su Lee et al.   Molecular Cancer

Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases

(2011) Marc Colombel et al.   PROSTATE

Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231

(2010) Monica Morini et al.   BMC CANCER

In silico Estimates of Tissue Components in Surgical Samples Based on Expression Profiling Data

(2010) Y. Wang et al.   CANCER RESEARCH

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

(2009) D M Berney et al.   BRITISH JOURNAL OF CANCER

MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02

(2009) Li-Yan Khor et al.   JOURNAL OF CLINICAL ONCOLOGY

TGFβ in Cancer

(2008) Joan Massagué   CELL

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer

(2008) Tobias Zellweger et al.   INTERNATIONAL JOURNAL OF CANCER

An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

(2008) Ittai Ben-Porath et al.   NATURE GENETICS